November 28, 2013 - Volume 27 - Issue 18
pp: F21-F28,2831-2972

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain

Kelly, Kathleen M.; Beck, Sarah E.; Pate, Kelly A. Metcalf; More

AIDS . 27(18):F21-F28, November 28, 2013.



DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge

Koopman, Gerrit; Beenhakker, Niels; Nieuwenhuis, Ivonne; More

AIDS . 27(18):2841-2851, November 28, 2013.

Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells

Wightman, Fiona; Lu, Hao K.; Solomon, Ajantha E.; More

AIDS . 27(18):2853-2862, November 28, 2013.


Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort

Ndumbi, Patricia; Gillis, Jennifer; Raboud, Janet M.; More

AIDS . 27(18):2863-2872, November 28, 2013.

Concise Communication



Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and...

Chung, Michael H.; McKenzie, Kevin P.; De Vuyst, Hugo; More

AIDS . 27(18):2909-2919, November 28, 2013.

Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM

van Aar, Fleur; Mooij, Sofie H.; van der Sande, Marianne A.B.; More

AIDS . 27(18):2921-2931, November 28, 2013.

Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models

van de Vijver, David A.M.C.; Nichols, Brooke E.; Abbas, Ume L.; More

AIDS . 27(18):2943-2951, November 28, 2013.

Concise Communication



In-vitro phenotypic susceptibility of HIV-1 ’non-B’ integrase inhibitors naive clinical isolates to dolutegravir and raltegravir

Charpentier, Charlotte; Bertine, Mélanie; Visseaux, Benoit; More

AIDS . 27(18):2959-2961, November 28, 2013.